Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Datasea Announces Entry into Agreements that Will Place its Acoustic High-Tech Products in a Total of 263 Beauty Stores in Northern China 2025-01-06 22:45
EMSRUN Medical Celebrates 15 Years of Excellence in Life-Saving Solutions 2025-01-06 22:10
Hanyang University, Korea's Pioneer in Industry-Academia Collaboration, Debuts First Independent Pavilion at CES 2025 2025-01-06 22:00
Technoderma Medicines Completes Positive Ph2a Proof- of Concept Trial with Topical TDM-180935 Ointment for Atopic Dermatitis 2025-01-06 21:00
Concord Medical Announces Result of 2024 Annual General Meeting 2025-01-06 20:30
I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program 2025-01-06 20:00
Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program 2025-01-06 18:05
Spectricity Unveils S1-A Accessory Device for Plug-n-Play Spectral Imaging on Mobile Platforms 2025-01-06 12:16
Docquity and HCDC Partner to Strengthen Preventive Medicine Education for Thousands of HCPs in Vietnam 2025-01-06 11:00
Innovent to Participate and Present at the 43rd Annual J.P. Morgan Healthcare Conference 2025-01-06 08:00
Episode Two "The Wisdom of the Shanghai School" of CMG's "China TCM Show" (Season 2) to air this weekend 2025-01-04 20:49
Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Atopic Dermatitis and Asthma Therapies Antibody Drug MG-K10 Late-Stage Clinical Trials and Commercialization 2025-01-03 21:15
GRIT Bio Appoints Jie Jia, Ph.D., as Chief Operating Officer 2025-01-03 15:30
Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene 2025-01-03 13:30
Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration 2025-01-03 08:00
CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial 2025-01-03 02:30
Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044 2025-01-03 01:43
Statement regarding the patent dispute between Cocrystal Technology and KANEKA Corporation in the United States 2025-01-02 21:30
PieX AI: Launching the World's First Personalized, On-device AI Pendant at CES 2025 2025-01-02 21:00
HKSH Symposium on Advances in Cancer Management 2024 Breakthroughs in Cancer Management 2025-01-02 17:50
1 4 5 6 7 8 1647